271.15
+1.00
+(0.37%)
At close: January 30 at 5:25:12 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
7,257,000.00
8,471,000.00
9,721,000.00
9,261,000.00
10,497,000.00
Investing Cash Flow
-27,733,000.00
-26,204,000.00
-6,044,000.00
733,000.00
-5,401,000.00
Financing Cash Flow
-5,254,000.00
21,048,000.00
-4,037,000.00
-8,271,000.00
-4,867,000.00
End Cash Position
9,011,000.00
10,944,000.00
7,629,000.00
7,989,000.00
6,266,000.00
Capital Expenditure
-974,000.00
-1,112,000.00
-936,000.00
-880,000.00
-608,000.00
Issuance of Debt
3,996,000.00
27,777,000.00
6,919,000.00
4,945,000.00
8,914,000.00
Repayment of Debt
-3,600,000.00
-1,454,000.00
--
-4,150,000.00
-6,450,000.00
Repurchase of Capital Stock
--
--
-6,360,000.00
-4,975,000.00
-3,486,000.00
Free Cash Flow
6,283,000.00
7,359,000.00
8,785,000.00
8,381,000.00
9,889,000.00
12/31/2020 - 5/26/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GS71.DU GSK PLC
16.81
+0.54%
4AB.SG AbbVie Inc
168.70
+0.29%
4AB0.F AbbVie Inc.
16.00
0.00%
BRM.MU Bristol-Myers Squibb Co
56.50
+0.34%
0O59.IL Sanofi
103.61
+2.01%
SANO.VI Sanofi
103.38
+1.55%
SNW.F Sanofi
103.28
+1.37%
4AB.F AbbVie Inc.
168.98
+0.07%
KLBF.JK PT Kalbe Farma Tbk.
1,250.00
+1.22%
4503.T Astellas Pharma Inc.
1,514.50
-0.95%